# PET Imaging CCR2 in Lung Inflammation

> **NCT03492762** · EARLY_PHASE1 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 110 (estimated)

## Conditions studied

- Lung Inflammation

## Interventions

- **DRUG:** Cu-DOTA-ECL1i

## Key facts

- **NCT ID:** NCT03492762
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-02-27
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03492762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03492762, "PET Imaging CCR2 in Lung Inflammation". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03492762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*